CT增强扫描后对比剂渗漏发生的影响因素分析

Abstract
Figure/Table
References (26)
Related Citation (1)

Download: PDF (450 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To analyze the influencing factors of contrast medium leakage after CT enhanced scan. Methods Data of 51 patients with contrast medium leakage after CT enhanced scan in Jiangsu Provincial People’s Hospital (hereinafter referred to as “our hospital”) from January 2019 to May 2021 were retrospectively collected and included in the occurrence group. Data of 51 patients without contrast medium leakage after CT enhanced scan in our hospital during the same period were collected and included in the non-occurrence group. Baseline data of the two groups were recorded and analyzed, scanning sites, injection sites, and contrast medium injection rates of the two groups were statistically analyzed, and logistic regression model was used to analyze the influencing factors of contrast medium leakage after CT enhanced scan. Results The proportion of patients with combined hypertension or diabetes mellitus or malignant tumor, forearm vena injection, and contrast medium injection rate were higher than those in the non-occurrence group, and the differences were statistically significant (P ＜ 0.05). Multivariate analysis showed that hypertension, diabetes mellitus, malignant tumor, forearm vena injection and rapid injection rate were independent risk factors for contrast medium leakage after CT enhanced scan (OR ＞ 1, P ＜ 0.05). Conclusion The contrast medium leakage after CT enhanced scan may be affected by a variety of factors, and the injection rate should be strictly controlled according to the specific situation of patients. For patients with the above risks, the contrast medium leakage should be closely observed and treated in time to ensure the quality of CT enhanced scan and the safety of patients’ lives.

Key words： CT enhanced scan Contrast medium leakage Injection site Injection rate

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GU Wencui1 LIN Hongxia2

Cite this article:

GU Wencui1 LIN Hongxia2. Analysis of influencing factors of contrast medium leakage after CT enhanced scan#br#[J]. 中国医药导报, 2022, 19(1): 162-165.

URL:

https://www.yiyaodaobao.com.cn/EN/ OR https://www.yiyaodaobao.com.cn/EN/Y2022/V19/I1/162

[1] Tsurumaru D，Miyasaka M，Muraki T，et al. Histopathologic diversity of gastric cancers：Relationship between enhancement pattern on dynamic contrast-enhanced CT and histological type [J]. Eur J Radiol，2017，86（97）：90-95.
[2] Sandfort V，Choi Y，Symons R，et al. An Optimized Test Bolus Contrast Injection Protocol for Consistent Coronary Artery Luminal Enhancement for Coronary CT Angiography [J]. Acad Radiol，2020，27（3）：371-380.
[3] 陈静，李梅.CT增强检查中碘对比剂外渗的原因及对策[J].实用临床医药杂志，2016，20（22）：194-195，197.
[4] 冯剑秋，孙小丽.CT增强扫描时大量造影剂外溢原因分析及防治措施[J].中国医药导报，2019，16（1）：141-144.
[5] 中国高血压防治指南修订委员会.中国高血压防治指南2010 [J].中华心血管病杂志，2011，39（7）：579-616.
[6] 中华医学会糖尿病学分会.中国2型糖尿病防治指南（2013年版）[J].中华内分泌代谢杂志，2014，30（10）：893-942.
[7] 中国成人血脂异常防治指南制定联合委员会.中国成人血脂异常防治指南[J].中华心血管病杂志，2007，35（5）：390-419.
[8] 中华医学会放射学分会，中国医师协会放射医师分会.对比剂使用指南（第1版）[J].中华放射学杂志，2008，42（3）：320-325.
[9] 胡晴，杨尚文，吕春艳，等.两种预注射方式在冠状动脉CT成像中预防对比剂外渗的效果观察[J].解放军护理杂志，2016，33（13）：74-76.
[10] 文雪柯，张斌，骆春柳，等.CT增强扫描中碘对比剂外渗护理干预的研究进展[J].护士进修杂志，2020，35（17）：1584-1587.
[11] Pasquini L，Napolitano A，Visconti E，et al. Gadolinium-Based Contrast Agent-Related Toxicities [J]. CNS Drugs，2018，32（3）：229-240.
[12] 黄婷婷，陈英，刘于.MDCT检查中碘对比剂静脉外渗的研究进展[J].护理学杂志，2019，34（16）：107-110.
[13] 陈丽媛，严华，陆永光，等.造影剂肾病对冠状动脉粥样硬化性心脏病患者短期预后的影响[J].中国现代医学杂志，2016，26（8）：71-75.
[14] Corines MJ，Nougaret S，Weiser MR，et al. Gadolinium-Based Contrast Agent During Pelvic MRI：Contribution to Patient Management in Rectal Cancer [J]. Dis Colon Rectum，2018，61（2）：193-201.
[15] 白静静，李健，雒娜，等.CT增强扫描中对比剂外渗的临床预防方法[J].医学影像学杂志，2017，27（11）：2196-2198.
[16] Markiewicz E，Fan X，Mustafi D，et al. MRI ductography of contrast agent distribution and leakage in normal mouse mammary ducts and ducts with in situ cancer [J]. Magn Reson Imaging，2017，35（40）：48-52.
[17] 陈昉铭，吴文娟，张雷，等.三期对比剂注射方案对头颈部CTA检查对比剂外渗率的影响[J].南京医科大学学报：自然科学版，2019，39（12）：1837-1840.
[18] 刘志芳，卢艳君，张碧红.PDCA管理在CT增强扫描患者造影剂外渗预防中的应用[J].海南医学，2019，30（22）：2990-2992.
[19] 黄建斌，曹林德，韦文桦，等.MSCT在对比剂外渗的急性腹部创伤性动脉损伤诊断中的应用价值[J].中国现代医生，2020，58（9）：144-146，193.
[20] Arens A，Vriens D，Janssen M，et al. Anakinra Injection Site Reaction on FDG PET/CT [J]. Clin Nucl Med，2015， 40（6）：492-493.
[21] 孟婧雅，沈旭慧，谢新芳.造影剂外渗的预防及护理新进展[J].护理研究，2018，32（8）：1193-1195.
[22] Lee SK，Lee D，Kim D，et al. Effect of catheter size and injection rate of contrast agent on enhancement and image quality for triple‐phase helical computed tomography of the liver in small dogs [J]. Vet Radiol Ultrasound，2017，58（6）：664-670.
[23] 任红红.磁共振增强扫描高压注射器造影剂外渗的护理研究[J].中国药物与临床，2018，18（1）：122-124.
[24] 赵丽，孙峥，尚洁，等.两种留置针穿刺角度配合不同对比剂注射速率在减少对比剂外渗中的效果研究[J].护士进修杂志，2020，35（17）：1553-1555.
[25] Karády J，Panajotu A，Kolossváry M，et al. The effect of four-phasic versus three-phasic contrast media injection protocols on extravasation rate in coronary CT angiography： a randomized controlled trial [J]. Eur Radiol，2017， 27（11）：4538-4543.
[26] 任丽，朱英，施素萍，等.CT增强扫描中非离子型对比剂注射速率致不良反应分析[J].中国医学计算机成像杂志，2016，22（5）：488-490.